19.45 0.00 (0.00%)
After hours: 4:39PM EDT
|Bid||11.25 x 4000|
|Ask||21.75 x 900|
|Day's Range||19.35 - 20.00|
|52 Week Range||11.95 - 20.00|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 6, 2018 - Aug 10, 2018|
|Forward Dividend & Yield||0.05 (0.26%)|
|1y Target Est||22.00|
Invacare Corporation (IVC) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
Invacare Corporation (IVC) today announced the appointment of Petra Danielsohn-Weil, PhD, to its Board of Directors, effective May 17, 2018. From 2014 until her retirement in August 2017, Ms. Danielsohn-Weil was the Regional President for Pfizer Essential Health - Europe, a leader in non-viral anti-infectives, biosimilars and sterile injectable medicines and a unit of Pfizer Inc. (PFE), a research-based, global biopharmaceutical company.
The Board of Directors of Invacare Corporation announced that it declared a cash dividend of $.0125 per share on its common shares and $.011364 per share on its Class B common shares payable July 20, 2018 to shareholders of record on July 6, 2018.
NEW YORK, May 14, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of PHH ...
On a per-share basis, the Elyria, Ohio-based company said it had a loss of 43 cents. Losses, adjusted for one-time gains and costs, came to 35 cents per share. The wheelchair, crutches and motorized scooter ...
Invacare Corporation announces that it will release its financial results for the first quarter ended March 31, 2018, after the market closes on Monday, May 7, 2018.
Invacare Corporation today announced the appointment of Kathleen P. Leneghan as Senior Vice President and Chief Financial Officer, effective immediately. Ms. Leneghan has been in the role of interim Chief Financial Officer of the company since November 26, 2017.
The Board of Directors of Invacare Corporation announced that it declared a cash dividend of $.0125 per share on its common shares and $.011364 per share on its Class B common shares payable April 18, 2018 to shareholders of record on April 4, 2018.
Invacare Corporation today announced that it will transfer production of Küschall® manual wheelchairs from its facility in Witterswil, Switzerland to its wheelchair manufacturing facility in Fondettes, France by the end of the third quarter 2018.
NEW YORK, NY / ACCESSWIRE / February 8, 2018 / Invacare Corporation (NYSE: IVC ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 8, 2018 at 8:30 AM Eastern Time. ...
The Elyria, Ohio-based company said it had a loss of 54 cents per share. Losses, adjusted for one-time gains and costs, came to 42 cents per share. The wheelchair, crutches and motorized scooter company ...
Invacare Corporation today announced its financial results for the fourth quarter and year ended December 31, 2017.
Does the share price for Invacare Corporation (NYSE:IVC) reflect it’s really worth? Today, I will calculate the stock’s intrinsic value using the discounted cash flow (DCF) method. Anyone interested inRead More...
Invacare Corporation announces that it will release its financial results for the fourth quarter and year ended December 31, 2017, after the market closes on Wednesday, February 7, 2018.
Invacare Corporation (NYSE:IVC), a medical equipment company based in United States, led the NYSE gainers with a relatively large price hike in the past couple of weeks. With many analystsRead More...
Matthew E. Monaghan, Chairman, President and Chief Executive Officer of Invacare Corporation , will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 11, 2018 at 9:30 a.m.